OB
Ovelle Bio Corp.
SEC filingBiotechnology · Dover, DE
Amount raised$7Msold at filing
Total offering$9.2M$2.2M still open
Investors in the raise1count reported to the SEC
FiledJun 10, 2026first sale Jun 2, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Travis Carleton PotterExecutive Officer
Merrick Carleton Pierson SmelaExecutive Officer
Executive officers, directors and promoters as listed on the Form D.